Allergy

1. MOERMANS C, Sabbe M, Onssels A, Bricmont N, et al
   Dupilumab Effectiveness in Biologic-Naive and Switched Severe Asthma in Real Life.
   Allergy. 2025 Dec 24. doi: 10.1111/all.70205.
   

   >> Share

   
   
2. POTO R, Chan R, Pelaia C, Canonica GW, et al
   The Role of Biologics in Reducing Mucous Plug Burden in Asthma.
   Allergy. 2025 Dec 23. doi: 10.1111/all.70197.
   

   >> Share

   
   

   
   Ann Thorac Surg

3. HAYANGA JWA, Voppuru S, Bham N, Hansen A, et al
   Higher Costs and Lower Reimbursement of Endobronchial Valve Therapy vs Lung Volume Reduction Surgery in the United States.
   Ann Thorac Surg. 2026;121:174-180.
   

   >> Share

   
   

   
   Arch Bronconeumol

4. ALMONACID C, Quirce S, Blanco M, Del Cubillo A, et al
   Inside GEMA 5.5: Expert Insights on the Latest Changes in Asthma Management.
   Arch Bronconeumol. 2025 Dec 2:S0300-2896(25)00418.
   

   >> Share

   
   
5. MARTINEZ-GARCIA MA, Aksamit T, Asakura T, Burr L, et al
   The Worldwide Puzzle of Bronchiectasis Etiology in Adults.
   Arch Bronconeumol. 2025 Dec 4:S0300-2896(25)00419.
   

   >> Share

   
   

   
   Can Respir J

6. HONG KK, Li GS, He RQ, Huang ZG, et al
   Upregulation of TFDP1 and CDC27 Plays an Important Role in Bronchiectasis.
   Can Respir J. 2025;2025:2891024.
   

   >> Share

   
   

   
   Chest

7. VYAS DA, Mein SA, Narasimmaraj PR, Tale AP, et al
   Asthma Morbidity and Medicaid Instability: Implications of National Work Requirements.
   Chest. 2025 Dec 30:S0012-3692(25)05953-7. doi: 10.1016/j.chest.2025.
   

   >> Share

   
   
8. FLUME P, Bullington W, Christon L, Crawford E, et al
   Structure of a Bronchiectasis and NTM Care Center: a Position Statement by the Bronchiectasis & NTM Association.
   Chest. 2025 Dec 18:S0012-3692(25)05928-8. doi: 10.1016/j.chest.2025.
   

   >> Share

   
   

   
   Clin Exp Allergy

9. PARIS D, Candia C, Molino A, D'Amato M, et al
   Benralizumab Affects Specific Compartments in Severe Asthma Patients With Chronic Rhinosinusitis and Nasal Polyposis.
   Clin Exp Allergy. 2025;55:1251-1254.
   

   >> Share

   
   

   
   J Asthma

10. INTILI G, Fucarino A, Burgio S, Amico MD, et al
    Ex vivo air-liquid interface respiratory mucosa platform to study type 2-driven Asthma.
    J Asthma. 2025 Dec 26:1-15. doi: 10.1080/02770903.2025.2608988.
    

    >> Share

    
    
11. AKCA SUMENGEN A, Gibson-Young LM, Buckner E, Dorsey L, et al
    Associations of Inhaler Technique, Medication Adherence, and Parental Illness Perception on Asthma Control in Childhood: A Cross-Sectional Observational Study.
    J Asthma. 2025 Dec 26:1-21. doi: 10.1080/02770903.2025.2610344.
    

    >> Share

    
    
12. ANDOH AA, Truelove A, Helwig S, Nash MC, et al
    Performance of the Asthma Clinical Score and the Pediatric Respiratory Assessment Measure in obese children presenting to the emergency department for asthma exacerbations.
    J Asthma. 2025 Dec 27:1-13. doi: 10.1080/02770903.2025.2610341.
    

    >> Share

    
    
13. MATSUMOTO T, Suga H, Kajiwara Y, Matoba T, et al
    Hidden burden: discrepancies between patient-reported and clinically documented severe asthma exacerbations.
    J Asthma. 2025 Dec 27:1-10. doi: 10.1080/02770903.2025.2610347.
    

    >> Share

    
    
14. YANG X, Guo Y, Bao M, Lu X, et al
    Therapeutic effects and metabolomics profiles of isoflavone extract of Belamcanda chinensis (L.) DC on house dust mite -induced allergic asthma mice.
    J Asthma. 2025 Dec 27:1-12. doi: 10.1080/02770903.2025.2610345.
    

    >> Share

    
    
15. PAUK N, Valena T, Krcmova I, Heribanova L, et al
    Real-world clinical experience with benralizumab for severe eosinophilic asthma in the Czech Republic: Fewer corticosteroids and better symptom control.
    J Asthma. 2025 Dec 27:1-13. doi: 10.1080/02770903.2025.2610346.
    

    >> Share

    
    
16. YU W, Peng Z, Lu B, Yu Y, et al
    Tanshinone IIA attenuates airway inflammation and airway remodeling in bronchial asthma by inhibiting p38/NF-kappaB and AKT/HIF-1alpha.
    J Asthma. 2025 Dec 22:1-13. doi: 10.1080/02770903.2025.2603318.
    

    >> Share

    
    

    
    Pediatr Allergy Immunol

17. HANSEN JB, Halken S, Agertoft L, Lund LC, et al
    Perfluoroalkyl substance exposure and risk of asthma at age 9 years.
    Pediatr Allergy Immunol. 2025;36:e70266.
    

    >> Share

    
    

    
    Pediatr Pulmonol

18. PRESTI S, Parisi GF, Tosto M, Nizzari A, et al
    Effect of Nirsevimab as a Primary Preventive Strategy on the Incidence, Severity, and Viral Etiology of Bronchiolitis: A Four-Year Observational Study.
    Pediatr Pulmonol. 2026;61:e71451.
    

    >> Share

    
    
19. HOGAN AH, Adams A, Brugge D, Beck AF, et al
    Mapping Bronchiolitis in Connecticut Before and After the COVID-19 Pandemic.
    Pediatr Pulmonol. 2026;61:e71450.
    

    >> Share

    
    
20. PLANTE V, Tabone L, Beck J, Sinderby C, et al
    A physiologic Comparison of Continuous Neurally Adjusted Ventilation (NeuroPAP) Versus Neurally-Adjusted Ventilatory Assist (NAVA) in Infants With Respiratory Failure.
    Pediatr Pulmonol. 2026;61:e71434.
    

    >> Share

    
    
21. KANAI R, Nagao M, Sato Y, Atsuta J, et al
    Early-Onset Wheeze Trajectories in Infants: The Phenotyping of Wheezing Infants (P-WIN) Study.
    Pediatr Pulmonol. 2025;60:e71437.
    

    >> Share

    
    
22. RASHID MM, Hu N, Chan M, Khan JR, et al
    Risk Factors for Asthma Readmission Among Australian Children- A Population-Based Cohort Study.
    Pediatr Pulmonol. 2025;60:e71433.
    

    >> Share

    
    

    
    Pediatr Rev

23. DE WAAL MALEFYT SK, Powers KE, Krugel C, Kaslovsky R, et al
    Asthma Uncovered: A Comprehensive Look at Epidemiology, Pathophysiology, and Diagnosis.
    Pediatr Rev. 2026;47:3-14.
    

    >> Share

    
    
24. FILLEY EP, Varghese NP
    Chronic Dyspnea and Acute Syncope in a 16-Year-Old Girl With Asthma.
    Pediatr Rev. 2026;47:44-49.
    

    >> Share

    
    

    
    PLoS One

25. KATARIA A, Daniel J, Isaac B, Thangakunam B, et al
    Predictors of depression in asthma patients in an Indian referral hospital.
    PLoS One. 2026;21:e0338126.
    

    >> Share

    
    

    
    Respir Med

26. CHEN F, Lu M, Ye J, Zhang L, et al
    Association between fractional exhaled nitric oxide (FeNO) and blood eosinophil count among children and adolescents with asthma in the United States: a population-based study.
    Respir Med. 2025 Dec 31:108630. doi: 10.1016/j.rmed.2025.108630.
    

    >> Share

    
    
27. DULAI V, Keglevich A, Santa B, Abonyi-Toth Z, et al
    Real-world efficacy of BDP/FF/G fixed triple inhalation powder (NEXThaler) therapy in the treatment of moderate to severe COPD patients (RESPONSE study).
    Respir Med. 2026;251:108498.
    

    >> Share

    
    
28. BREA TP, Sanz CZ, Lado-Baleato O, Gude F, et al
    Prognostic influence of cardiac comorbidities in chronic obstructive pulmonary disease.
    Respir Med. 2026;251:108544.
    

    >> Share

    
    
29. WU Z, Wang D, Tang C
    Comorbid management of chronic obstructive pulmonary disease and heart failure.
    Respir Med. 2026;251:108575.
    

    >> Share

    
    
30. JIANG D, Wang M
    Reciprocal association between chronic obstructive pulmonary disease and gastrointestinal diseases: A prospective cohort study.
    Respir Med. 2026;251:108589.
    

    >> Share

    
    
31. MORIKAWA Y, Morimoto K, Kodani T, Miyahara Y, et al
    Safety and efficacy of a helium-oxygen mix for pediatric respiratory failure associated with anatomical and functional stenotic lesions of the airway: a phase II clinical trial.
    Respir Med. 2026;251:108592.
    

    >> Share

    
    
32. ROHDE G, Vogelmeier CF, Beeh KM, Kardos P, et al
    TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: Up to 12 months interim analysis.
    Respir Med. 2026;251:108597.
    

    >> Share

    
    
33. MARRADES P, De Angelis A, Iorfida A, Perea L, et al
    Bronchiectasis and treatable traits: the journey from concept to clinical practice.
    Respir Med. 2026;251:108593.
    

    >> Share

    
    
34. LAU CE, van der Burg NMD, Ankerst J, Bjermer L, et al
    ADAM17 and related epithelial injury markers in bronchoalveolar lavage and blood distinguish COPD from controls.
    Respir Med. 2026;251:108596.
    

    >> Share

    
    
35. JESENAK M, Bobcakova A, Golebski K, Krohn IK, et al
    Airway epithelial barrier integrity: an emerging treatable trait in asthma management.
    Respir Med. 2025;252:108579.
    

    >> Share

    
    
36. BARISIONE G, Stanojevic S, Brusasco V
    Zone of z-scores uncertainty in pulmonary function interpretation: A proof-of-concept study from CO and NO lung diffusing capacities.
    Respir Med. 2026;251:108600.
    

    >> Share

    
    
37. DOMAGALA-MANCZYK I, Miszczuk-Ciesla M, Maskey-Warzechowska M, Zielecki M, et al
    Limitation of the effectiveness of inhalation training in patients with asthma and COPD.
    Respir Med. 2026;251:108603.
    

    >> Share

    
    
38. CLARK VL, de Oliveira JM, Gibson PG, McDonald VM, et al
    Prevalence and overlap of treatable traits in severe asthma and COPD: A cross-disease comparison in a tertiary care setting.
    Respir Med. 2025;252:108604.
    

    >> Share

    
    
39. CARVALHAL G, Diniz JM, Hespanhol LC, Barbosa Izoton Cabral DC, et al
    Exacerbation risk in patients with bronchiectasis receiving DPP-1 inhibitors vs placebo: A meta-analysis of RCTs.
    Respir Med. 2026;251:108607.
    

    >> Share

    
    
40. JANSON C, Malinovschi A, Borres M, Faner R, et al
    Allergic sensitization in asthma and COPD in the NOVELTY study.
    Respir Med. 2026;251:108605.
    

    >> Share

    
    

    
    Respir Res

41. PIPARIA S, Kho AT, Desai B, Wong R, et al
    A principal component analysis-based endophenotype definition for change in lung function and inhaled corticosteroid treatment response in childhood asthma.
    Respir Res. 2025;26:351.
    

    >> Share

    
    
42. LEE SE, Kim BK, Kang N, Lee Y, et al
    Asthma remission and its predictors in severe asthma: real-world study from the Korean severe asthma registry.
    Respir Res. 2025 Dec 27. doi: 10.1186/s12931-025-03451.
    

    >> Share

    
    
43. WANG K, Wu R, Fan M, Jia R, et al
    CPA3 drives the development of asthma by promoting the activation of the JAK/STAT6 pathway.
    Respir Res. 2025 Dec 23. doi: 10.1186/s12931-025-03456.
    

    >> Share

    
    
44. DENG Y, Hall JK, Wang Y, Kim JH, et al
    Imaging the extracellular matrix structure and remodeling in healthy, fibrotic, and emphysematous human precision-cut lung slices.
    Respir Res. 2025 Dec 22. doi: 10.1186/s12931-025-03464.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share